AndreaBozzo/ceres-open-data-index huggingface dataset:
Compound 526371: 1,2,4,6,8-Pentabromo-dibenzo-dioxin

Chemical compound data from PubChem database. IUPAC Name: 1,2,4,6,8-pentabromodibenzo-p-dioxin. Molecular Formula: C12H3Br5O2. Molecular Weight: 578.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Anthropometric Database for the EMTs in the United States

Deaths or serious injuries among emergency medical technicians (EMTs) and other ambulance occupants occur at a high rate during transport. According to a study by the National Institute for Occupational Safety and Health (NIOSH), EMTs and paramedics have higher fatality rates when compared to all workers, with forty-five percent of EMT deaths resulting from highway incidents, primarily due to vehicle collisions.1 Data from the National Highway and Traffic Safety Administration showed that among the persons killed in crashes involving an ambulance between 1992 and 2011, twenty one percent were EMTs and patients, while four percent were ambulance drivers.2 To reduce injury potential to the EMTs and other ambulance occupants, NIOSH, the Department of Homeland Security, the U.S. General Services Administration, and the National Institute of Standards and Technology, along with private industry partners, have committed to improving the workspace design of ambulance patient compartments for safe and effective perfo
Compound 526394: 1-Bromo,3,6,8-trichloro-dibenzo-dioxin

Chemical compound data from PubChem database. IUPAC Name: 1-bromo-3,6,8-trichlorodibenzo-p-dioxin. Molecular Formula: C12H4BrCl3O2. Molecular Weight: 366.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
NNDSS - TABLE 1JJ. Tuberculosis to Tularemia

NNDSS - TABLE 1JJ. Tuberculosis to Tularemia – 2020. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents.

Notice: Tuberculosis data for weeks 4-31 are incorrect for New York City; the Middle Atlantic region total; U.S. Residents, excluding U.S. Territories total; and the grand total, due to data processing issues. 
Notice: Tuberculosis data for weeks 32-33 are incorrect for the U.S. Residents, excluding U.S. Territories total and the grand total, due to data processing issues. 

Note:
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html.

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published.
NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
Cum: Cumulative year-to-date counts.
Max: Maximum — Maximum case count during the previous 52 weeks.
* Case counts for reporting years 2019 and 2020 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf.
†Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
Compound 527172: 4a,8-Dimethyl-5,6,7,8-tetrahydronaphthalen-2-one

Chemical compound data from PubChem database. IUPAC Name: 4a,8-dimethyl-5,6,7,8-tetrahydronaphthalen-2-one. Molecular Formula: C12H16O. Molecular Weight: 176.25. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
NNDSS - TABLE 1V. Malaria to Measles, Imported

NNDSS - TABLE 1V. Malaria to Measles, Imported - 2019. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents. 

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. 

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published — CDC does not have data because of changes in how conditions are categorized.
Cum: Cumulative year-to-date counts.
Max: Maximum — Maximum case count during the previous 52 weeks.
* Case counts for reporting years 2018 and 2019 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the US, a US territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-US Residents' category. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf. 
† Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
Compound 529521: L-Tryptophan, N,1-bis(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester

Chemical compound data from PubChem database. IUPAC Name: [tert-butyl(dimethyl)silyl] 2-[[tert-butyl(dimethyl)silyl]amino]-3-[1-[tert-butyl(dimethyl)silyl]indol-3-yl]propanoate. Molecular Formula: C29H54N2O2Si3. Molecular Weight: 547.0. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525267: N'-(3-chloro-phenyl)-N,N-dimethyl-acetamidine

Chemical compound data from PubChem database. IUPAC Name: N'-(3-chlorophenyl)-N,N-dimethylethanimidamide. Molecular Formula: C10H13ClN2. Molecular Weight: 196.67. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528908: 5-Ethenyl-5-(1-methyl-3-butenyl)-hexahydropyrimidine-2,4,6-trione

Chemical compound data from PubChem database. IUPAC Name: 5-ethenyl-5-pent-4-en-2-yl-1,3-diazinane-2,4,6-trione. Molecular Formula: C11H14N2O3. Molecular Weight: 222.24. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526334: 2,4,9-Tribromo-dibenzofuran

Chemical compound data from PubChem database. IUPAC Name: 1,6,8-tribromodibenzofuran. Molecular Formula: C12H5Br3O. Molecular Weight: 404.88. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Levofloxacin

Levofloxacin is a prescription antibiotic solution used to treat bacterial infections. It belongs to the fluoroquinolone class and is taken orally. Manufactured by Lannett Company, Inc., it comes in strengths like 25 mg/mL in bottles of 100 mL, 200 mL, or 480 mL. This information was generated using AI and is provided for informational and research purposes only.
Compound 530231: Bis(trimethylsilyl)sarcosine

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 2-[methyl(trimethylsilyl)amino]acetate. Molecular Formula: C9H23NO2Si2. Molecular Weight: 233.45. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
The effects of isatin (indole-2, 3-dione) on pituitary adenylate cyclase-activating polypeptide-induced hyperthermia in rats

Background
          Previous studies have demonstrated that centrally administered natriuretic peptides and pituitary adenylate cyclase-activating polypeptide-38 (PACAP-38) have hyperthermic properties. Isatin (indole-2, 3-dione) is an endogenous indole that has previously been found to inhibit hyperthermic effects of natriuretic peptides. In this study the aim was to investigate the effects of isatin on thermoregulatory actions of PACAP-38, in rats.
        
        
          Results
          One μg intracerebroventricular (icv.) injection of PACAP-38 had hyperthermic effect in male, Wistar rats, with an onset of the effect at 2 h and a decline by the 6th h after administration. Intraperitoneal (ip.) injection of different doses of isatin (25-50 mg/kg) significantly decreased the hyperthermic effect of 1 μg PACAP-38 (icv.), whereas 12.5 mg/kg isatin (ip.) had no inhibiting effect. Isatin alone did not modify the body temperature of the animals.
        
        
          Conclusion
          The mechanisms that participate in the mediation of the PACAP-38-induced hyperthermia may be modified by isatin. The capability of isatin to antagonize the hyperthermia induced by all members of the natriuretic peptide family and by PACAP-38 makes it unlikely to be acting directly on receptors for natriuretic peptides or on those for PACAP in these hyperthermic processes.
Patent AT-E399783-T1: [Translated] CRYSTALLINE FORM OF A FLUOROCHINOLONE-ARGININE SALT

The invention relates to the new arginine salt forms of RS-(.plusmn.)-9-fluo ro- 6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1H,5H- benzo~i,j~quinolizine-2-carboxylic acid, S-(-)-9-fluoro-6,7-dihydro-8-(4- hydroxypiperidin-1-yl)-5-methyl-1-oxo-1H,5H-benzo~i,j~quinolizine-2-carboxyl ic acid, R-(+)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo- 1H,5H-benzo~i,j~quinolizine-2-carboxylic acid, a process for their preparati on and pharmaceutical formulations which comprise those arginine salt forms as the active ingredient for its use in treating microbial infections.
Sodium nitroprusside

Sodium Nitroprusside is a prescription injectable medication used intravenously to rapidly lower high blood pressure in emergency situations, such as hypertensive crises. It works by relaxing blood vessels, helping to reduce strain on the heart. Manufactured by Meitheal Pharmaceuticals Inc. under ANDA211016, it's available as a 25 mg/mL solution. This information was generated using AI and is provided for informational and research purposes only.
Compound 530541: 3-Cyclopentylpropionic acid, pentyl ester

Chemical compound data from PubChem database. IUPAC Name: pentyl 3-cyclopentylpropanoate. Molecular Formula: C13H24O2. Molecular Weight: 212.33. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
New Mexico: 2011-2012 NSDUH

This report presents New Mexico\'s estimates for 25 measures of substance use and mental health based on the combined 2011 and 2012 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided by State and for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Clinical treatment reverses attentional deficits in congestive heart failure

Background
          Congestive heart failure (CHF) is associated with cognitive deficits, particularly of memory and attention. The present study aims to clarify whether clinical treatment can reverse the attentional deficits of patients with CHF.
        
        
          Methods
          A convenience sample of 50 patients with CHF functional class IV and 30 elderly controls were recruited from a teaching hospital in Brazil. Participants received a clinical and cognitive examination that included the Mini-Mental State Examination (MMSE), Cambridge Cognitive Examination of the Elderly (CAMCOG), Digit Span, Digit-Symbol Substitution, and Letter Cancellation test. The cognitive performance of CHF patients was reassessed 6 weeks after the introduction of clinical treatment.
        
        
          Results
          Twenty-seven CHF subjects had MMSE<24, compared to only 10 of the controls (p = 0.07). CHF patients also had lower CAMCOG scores (mean = 71.8) than controls (mean = 82.0; p < 0.01). Digit Span, Digit Symbol and Letter Cancellation scores were lower for patients with CHF than controls (p < 0.01). Similarly patients with CHF took longer to complete the Trail Making A (p = 0.07) and B (p < 0.01). CAMCOG scores and left ventricular ejection fraction were moderately correlated (rho = 0.4, p < 0.01). Nineteen patients were lost for follow-up (11 deceased). Clinical treatment was associated with significant improvement of cognitive scores, particularly on the Digit Symbol (p < 0.01) and Letter Cancellation Tests (p < 0.01). Digit Span, Digit Symbol, Letter Cancellation and Trail Making scores of treated CHF patients and controls were similar (p > 0.10).
        
        
          Conclusions
          CHF is associated with deficits in attention and psychomotor speed. These deficits improve with clinical treatment.
SHIP Emergency Department Visits For Addictions-Related Conditions 2008-2017

Emergency Department Visits For Addictions-Related Conditions - This indicator shows the rate of emergency department visits related to substance abuse disorders* (per 100,000 population). Substance abuse problems can place a heavy burden on the healthcare system, particularly when persons in crisis utilize emergency departments instead of other sources of care when available. In Maryland, there were 96,991 emergency department visits for substance-related disorders from 2012-2014.*Diagnoses include alcohol-related disorders and drug-related disorders.
Kinetic comparison of tissue non-specific and placental human alkaline phosphatases expressed in baculovirus infected cells: application to screening for Down's syndrome

Background
          In humans, there are four alkaline phosphatases, and each form exibits a characteristic pattern of tissue distribution. The availability of an easy method to reveal their activity has resulted in large amount of data reporting correlations between variations in activity and illnesses. For example, alkaline phosphatase from neutrophils of mothers pregnent with a trisomy 21 fetus (Down's syndrome) displays significant differences both in its biochemical and immunological properties,  and in its affinity for some specific inhibitors.
        
        
          Results
          To analyse these differences, the biochemical characteristics of two isozymes (non specific and placental alkaline phosphatases) were expressed in baculovirus infected cells. Comparative analysis of the two proteins allowed us to estimate the kinetic constants of denaturation and sensitivity to two inhibitors (L-p-bromotetramisole and thiophosphate), allowing better discrimination between the two enzymes. These parameters were then used to estimate the ratio of the two isoenzymes in neutrophils of pregnant mothers with or without a trisomy 21 fetus. It appeared that the placental isozyme represented 13% of the total activity of neutrophils of non pregnant women. This proportion did not significantly increase with normal pregnancy. By contrast, in pregnancies with trisomy 21 fetus, the proportion reached 60–80% of activity.
        
        
          Conclusion
          Over-expression of the placental isozyme compared with the tissue-nonspecific form in neutrophils of mother with a trisomy 21 fetus may explain why the characteristics of the alkaline phosphatase in these cells is different from normal. Application of this knowledge could improve the potential of using alkaline phosphatase measurements to screen for Down's syndrome.
Compound 529076: 1H-Pyrrole, ethylmethyl-

Chemical compound data from PubChem database. IUPAC Name: 2-ethyl-1-methylpyrrole. Molecular Formula: C7H11N. Molecular Weight: 109.17. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529972: Heneicosane, 10-ethyl-11-methyl

Chemical compound data from PubChem database. IUPAC Name: 10-ethyl-11-methylhenicosane. Molecular Formula: C24H50. Molecular Weight: 338.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Prevalence and Mean of Dental Caries (Cavities) among Maryland School Children, 2005-2006

This is historical data. The update frequency has been set to "Static Data" and is here for historic value. Updated 8/14/2024. 

This is the weighted prevalence of 1,276 schoolchildren.  1,276 out of 1,280 cases examined had prevalence available. One out of 1,276 cases had grade information missed, 564 were in Kindergarten and 711 in 3rd grade.  Prevalence is defined as occurrence of any caries among all selected population.  Mean is the average number of teeth with caries among students with caries in the selected population.  Region Identifiers and Constituent Counties:	
Western (Allegany, Frederick, Garrett, Washington); Central D.C. (Howard, Montgomery, Prince George’s); Southern (Calvert, Charles, St. Mary’s); Central Baltimore (Anne Arundel, Baltimore City, Baltimore County, Carroll, Harford); Eastern Shore (Caroline, Cecil, Dorchester, Kent, Queen Anne’s, Somerset, Talbot, Wicomico, Worcester).
Patent AT-E399939-T1: [Translated] DEVICE FOR STORING THERMAL ENERGY FOR SUBSEQUENT CONVERSION INTO ELECTRICAL ENERGY

The device has at least one heat energy and pressure storage module. Each of these has a heat input transmission device (1) and a pressure reservoir (2). These are connected to each other for exchange of fluid (30). An energy conversion device is connected to the pressure reservoir for fluid exchange, and the energy accumulated as fluid pressure in the module, is converted into a second energy. The device may have several modules connected to a distributor (40), which intermittendly connects individual modules to the energy conversion device. The device is formed by a hydraulic motor (5) and an optional generator (6) connected to it. It has a heat exchanger (35) connected to it, which is connected via a circulation pump (9) to the solar connector. The heat input transmission device is a solar collector or an IC engine.
Compound 527806: Benzoic acid, 4-chloro, 2,2-dichloroethyl ester

Chemical compound data from PubChem database. IUPAC Name: 2,2-dichloroethyl 4-chlorobenzoate. Molecular Formula: C9H7Cl3O2. Molecular Weight: 253.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527588: 2-Propyn-1-ol, dibromoacetate

Chemical compound data from PubChem database. IUPAC Name: prop-2-ynyl 2,2-dibromoacetate. Molecular Formula: C5H4Br2O2. Molecular Weight: 255.89. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Publications Using SAMHSA Data2011 CMHS Uniform Reporting System (URS) Output Tables for New Hampshire

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2011. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Pillbox (retired January 28, 2021)

This resource was retired on January 28, 2021 and is no longer updated.  These data remain available to support research and development efforts.  Pillbox's final image library is available at https://ftp.nlm.nih.gov/projects/pillbox/pillbox_production_images_full_202008.zip.  For more information on Pillbox's retirement visit https://www.nlm.nih.gov/pubs/techbull/ja20/ja20_pillbox_discontinue.html.

Pillbox contains metadata for oral solid dosage form medications, derived from FDA drug labeling, including physical characteristics, active and inactive ingredients, National Drug Codes, information about firms marketing those products, selected information from RxNorm, and links to images provided by the National Library of Medicine.
Patent AT-E400243-T1: [Translated] FAT-FREE SUNSCREEN

Fat-free cosmetic or dermatological composition comprises a titanium dioxide pigment, 2-phenylbenzimidazole-5-sulfonic acid (I) and 2,2'-methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol) (II).  An Independent claim is also included for production of the composition by dispersing the titanium dioxide and (II) separately or together in one or two portions of an aqueous phase, dispersing (I) in another portion of the aqueous phase, and combining and homogenizing the aqueous phases.